Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17799145 | 1.00 | KMT2A (0.43) | KMT2ACA1CA2CA4ALDH1A1 | |
| SCHEMBL30982279 | 1.00 | KMT2A (0.43) | KMT2ACA1CA2CA4ALDH1A1 | |
| SCHEMBL6244928 | 1.00 | KMT2A (0.43) | KMT2ACA1CA2CA4ALDH1A1 | |
| SCHEMBL768641 | 0.82 | — | — | |
| SCHEMBL6055693 | 0.75 | KMT2A (0.34) | KMT2ACA1CA2CA4ALDH1A1 | |
| SCHEMBL4314429 | 0.73 | KMT2A (0.63) | KMT2ACA1CA2CA4ALDH1A1 | |
| SCHEMBL15442331 | 0.73 | KMT2A (0.76) | KMT2ACA1CA2CA4ALDH1A1 | |
| SCHEMBL7524222 | 0.73 | KMT2A (0.63) | KMT2ACA1CA2CA4ALDH1A1 | |
| SCHEMBL4320907 | 0.73 | KMT2A (0.52) | KMT2ACA1CA2CA4ALDH1A1 | |
| SCHEMBL4320902 | 0.73 | KMT2A (0.52) | KMT2ACA1CA2CA4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118251207-A | Fragrance composition with moisturizing benefit | 弗门尼舍有限公司 | 2024-06-25 | — | — | CN | disclosed |
| WO-2020067079-A1 | METHOD FOR PRODUCING 3-METHYLCYCLOALKENONE COMPOUND | 高砂香料工業株式会社 | 2020-04-02 | — | — | WO | disclosed |
| EP-1687068-B1 | SPIROEPOXY-MACROCYCLE AS PERFUMING INGREDIENT | FIRMENICH & CIE (CH) | 2016-03-09 | — | — | EP | disclosed |
| US-20120015009-A9 | Multi-phased personal care composition comprising a blooming perfume composition | THE PROCTER & GAMBLE COMPANY | 2012-01-19 | — | — | US | disclosed |
| EP-1529770-B1 | Aldehyde as perfuming or flavoring ingredient | FIRMENICH & CIE (CH) | 2011-08-17 | — | — | EP | disclosed |
| EP-2337544-A2 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | Living Proof, Inc. (US) | 2011-06-29 | — | — | EP | disclosed |
| US-20090068255-A1 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | LIVING PROOF, INC. | 2009-03-12 | — | — | US | disclosed |
| WO-2008134712-A2 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | LIVING PROOF, INC. (US) | 2008-11-06 | — | — | WO | disclosed |
| WO-2008070368-A2 | METHODS AND COMPOSITIONS FOR SKIN CARE | LIVING PROOF, INC. (US) | 2008-06-12 | — | — | WO | disclosed |
| US-20070280976-A1 | Multi-phased personal care composition comprising a blooming perfume composition | THE PROCTER & GAMBLE COMPANY | 2007-12-06 | — | — | US | disclosed |
| US-7115552-B2 | Spiroepoxy-macrocycle as perfuming ingredient | FIRMENICH SA (CH) | 2006-10-03 | — | — | US | disclosed |
| EP-1687068-A1 | SPIROEPOXY-MACROCYCLE AS PERFUMING INGREDIENT | FIRMENICH SA (CH) | 2006-08-09 | — | — | EP | disclosed |
| US-20060148673-A1 | Spiroepoxy-macrocycle as perfuming ingredient | FIRMENICH SA (CH) | 2006-07-06 | — | — | US | disclosed |
| US-6933265-B2 | Aldehyde as perfuming or flavoring ingredient | FIRMENICH SA (CH) | 2005-08-23 | — | — | US | disclosed |
| US-20050101498-A1 | ALDEHYDE AS PERFUMING OR FLAVORING INGREDIENT | FIRMENICH SA (CH) | 2005-05-12 | — | — | US | disclosed |
| WO-2005039521-A1 | SPIROEPOXY-MACROCYCLE AS PERFUMING INGREDIENT | FIRMENICH SA (CH) | 2005-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090068255-A1 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | MMP1, MMP9, MMP17 | KMT2A 2537/4885CA1 4573/4885CA2 2297/4885 |
| US-20050101498-A1 | ALDEHYDE AS PERFUMING OR FLAVORING INGREDIENT | ALDH1A1, ALDH5A1, ALDH18A1 | KMT2A 2138/4885CA1 2907/4885CA2 3517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.